FDA Clarifies Approach to Genomic Alterations in Animals
May 02, 2024
May 02, 2024
WASHINGTON, May 2 -- The U.S. Department of Health and Human Services' Food and Drug Administration issued the following news release on May 1, 2024:
Today, the U.S. Food and Drug Administration took important steps to advance the FDA's regulatory process for intentional genomic alterations (IGAs) in animals. The updated guidance documents underscore the agency's commitment to further modernize its approach to evaluating and supporting the development of innovative animal and veteri . . .
Today, the U.S. Food and Drug Administration took important steps to advance the FDA's regulatory process for intentional genomic alterations (IGAs) in animals. The updated guidance documents underscore the agency's commitment to further modernize its approach to evaluating and supporting the development of innovative animal and veteri . . .